COMEDK 2007 MCQ Answer 66
on
with
0 comments
The correct answer is D
The combination of amphotericin B and intralipid should not be given to patients
The combination of amphotericin B and intralipid should not be given to patients
- Intralipid does not decrease the renal toxicity and subjective side effects associated with intravenous amphotericin B at a dose of 0.75
mg/kg/day in neutropenic cancer patients
- Use of amphotericin B in intralipid 20% can be associated with transient pulmonary toxicity, possibly related to fat overload
- On the basis of published data, amphotericin B and intralipid 20% should be regarded as chemically incompatible
Tags:
Category:
Subscribe to:
Post Comments (Atom)
POST COMMENT
0 comments:
Post a Comment